1527 related articles for article (PubMed ID: 24048066)
1. The causes and consequences of genetic heterogeneity in cancer evolution.
Burrell RA; McGranahan N; Bartek J; Swanton C
Nature; 2013 Sep; 501(7467):338-45. PubMed ID: 24048066
[TBL] [Abstract][Full Text] [Related]
2. Tumour heterogeneity and resistance to cancer therapies.
Dagogo-Jack I; Shaw AT
Nat Rev Clin Oncol; 2018 Feb; 15(2):81-94. PubMed ID: 29115304
[TBL] [Abstract][Full Text] [Related]
3. Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment.
Sun XX; Yu Q
Acta Pharmacol Sin; 2015 Oct; 36(10):1219-27. PubMed ID: 26388155
[TBL] [Abstract][Full Text] [Related]
4. Tumour heterogeneity and the evolution of polyclonal drug resistance.
Burrell RA; Swanton C
Mol Oncol; 2014 Sep; 8(6):1095-111. PubMed ID: 25087573
[TBL] [Abstract][Full Text] [Related]
5. Genomic evolution of cancer models: perils and opportunities.
Ben-David U; Beroukhim R; Golub TR
Nat Rev Cancer; 2019 Feb; 19(2):97-109. PubMed ID: 30578414
[TBL] [Abstract][Full Text] [Related]
6. Evolving insights: how DNA repair pathways impact cancer evolution.
Zhou J; Zhou XA; Zhang N; Wang J
Cancer Biol Med; 2020 Nov; 17(4):805-827. PubMed ID: 33299637
[TBL] [Abstract][Full Text] [Related]
7. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.
McGranahan N; Swanton C
Cell; 2017 Feb; 168(4):613-628. PubMed ID: 28187284
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer.
Mengelbier LH; Karlsson J; Lindgren D; Valind A; Lilljebjörn H; Jansson C; Bexell D; Braekeveldt N; Ameur A; Jonson T; Kultima HG; Isaksson A; Asmundsson J; Versteeg R; Rissler M; Fioretos T; Sandstedt B; Börjesson A; Backman T; Pal N; Øra I; Mayrhofer M; Gisselsson D
Nat Commun; 2015 Jan; 6():6125. PubMed ID: 25625758
[TBL] [Abstract][Full Text] [Related]
9. Genomic Instability in Cancer: Teetering on the Limit of Tolerance.
Andor N; Maley CC; Ji HP
Cancer Res; 2017 May; 77(9):2179-2185. PubMed ID: 28432052
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies.
Lee JK; Choi YL; Kwon M; Park PJ
Annu Rev Pathol; 2016 May; 11():283-312. PubMed ID: 26907526
[TBL] [Abstract][Full Text] [Related]
11. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution.
McGranahan N; Swanton C
Cancer Cell; 2015 Jan; 27(1):15-26. PubMed ID: 25584892
[TBL] [Abstract][Full Text] [Related]
12. Genetic and non-genetic clonal diversity in cancer evolution.
Black JRM; McGranahan N
Nat Rev Cancer; 2021 Jun; 21(6):379-392. PubMed ID: 33727690
[TBL] [Abstract][Full Text] [Related]
13. The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome.
Caswell DR; Swanton C
BMC Med; 2017 Jul; 15(1):133. PubMed ID: 28716075
[TBL] [Abstract][Full Text] [Related]
14. A population genetics perspective on the determinants of intra-tumor heterogeneity.
Hu Z; Sun R; Curtis C
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):109-126. PubMed ID: 28274726
[TBL] [Abstract][Full Text] [Related]
15. Intra-tumour heterogeneity - going beyond genetics.
Caiado F; Silva-Santos B; Norell H
FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
[TBL] [Abstract][Full Text] [Related]
16. Genetic insights into the morass of metastatic heterogeneity.
Hunter KW; Amin R; Deasy S; Ha NH; Wakefield L
Nat Rev Cancer; 2018 Apr; 18(4):211-223. PubMed ID: 29422598
[TBL] [Abstract][Full Text] [Related]
17. [Genetic instability, a factor limiting the efficiency of targeted therapies in solid oncology].
Billaud A; Chevalier LM; Campone M; Morel A; Bigot F
Bull Cancer; 2020 Nov; 107(11):1161-1170. PubMed ID: 33070953
[TBL] [Abstract][Full Text] [Related]
18. Tumour heterogeneity and immune-modulation.
Jamal-Hanjani M; Thanopoulou E; Peggs KS; Quezada SA; Swanton C
Curr Opin Pharmacol; 2013 Aug; 13(4):497-503. PubMed ID: 23664091
[TBL] [Abstract][Full Text] [Related]
19. Implications of genetic heterogeneity in cancer.
Schmitt MW; Prindle MJ; Loeb LA
Ann N Y Acad Sci; 2012 Sep; 1267():110-6. PubMed ID: 22954224
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer analysis of the extent and consequences of intratumor heterogeneity.
Andor N; Graham TA; Jansen M; Xia LC; Aktipis CA; Petritsch C; Ji HP; Maley CC
Nat Med; 2016 Jan; 22(1):105-13. PubMed ID: 26618723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
